Sunday, 29 September 2019

Bangladesh bans heartburn drug ranitidine over cancer fears

Bangladesh's drug regulatory authority on Sunday issued a ban on sales of popular heartburn drug ranitidine while it investigates a potential cancer-causing substance in the drug.


No comments:

Post a Comment